Hälsa & medicin

Researchers have advanced techniques for creating functional cardiac tissue from cells outside the body, potentially transforming how pharmaceutical companies test heart drugs before human trials. The development could reduce reliance on animal testing and accelerate the path to market for cardiovascular medicines.EN

Researchers report that IgA nephropathy, a leading cause of kidney failure worldwide, can be managed more effectively using non-immunosuppressive treatments. The finding could reshape clinical practice and reduce side effects for thousands of patients, while lowering healthcare costs associated with aggressive drug regimens.EN

Researchers have discovered that cells retain an epigenetic memory of hunger, priming them to activate autophagy—a cellular recycling process—when nutrients become scarce again. The finding could reshape strategies for treating metabolic diseases, cancer, and aging-related conditions where controlling cellular stress responses determines patient outcomes.EN

A new Science study reveals that multisystem inflammatory syndrome in children stems from abnormal immune cell activation triggered by past viral infection. The finding could reshape treatment approaches for this rare but serious post-infection complication and inform strategies for managing long-term effects of viral diseases.EN

Researchers have found that epigenetic modifications—chemical tags that switch genes on and off—influence how patients respond to urinary tract infections. The discovery could eventually help clinicians identify high-risk patients early and tailor treatments, potentially reducing complications and antibiotic overuse.EN

A case report in JAMA Oncology documents severe skin ulcers in a myelodysplastic syndrome patient, highlighting an overlooked risk from cancer treatments. The finding could prompt oncologists to screen patients more carefully and drugmakers to reassess safety profiles of existing therapies.EN

Researchers have identified a new role for CD8+ T cells in rheumatoid arthritis immunity, potentially opening doors to better treatments. The finding could reshape how drugmakers and clinicians approach RA, a costly autoimmune disease affecting millions globally and driving significant healthcare spending.EN

A new study in Lancet Healthy Longevity finds that patients with several cardiometabolic conditions simultaneously—such as diabetes, heart disease, and obesity—experience steeper cognitive deterioration than those with single diseases. The finding has implications for healthcare systems weighing preventive interventions and insurers assessing risk profiles in aging populations.EN

Researchers have decoded the structure and function of a critical cellular protein that controls sodium and acid levels in mammalian cells. The discovery could unlock new drug targets for conditions linked to ion imbalance, from kidney disease to neurological disorders, potentially opening a new class of therapeutics.EN

A new Swedish study documents cases of idiopathic intracranial hypertension—a serious condition causing increased pressure around the brain—in young patients receiving hormone therapy for gender dysphoria. The finding raises questions about monitoring protocols and informed consent practices in pediatric gender medicine, a rapidly expanding treatment area facing growing regulatory scrutiny.EN

A major review of existing studies and new population data confirms a significant association between type 2 diabetes and attention-deficit/hyperactivity disorder. The finding could reshape how clinicians screen patients and has implications for insurers and employers managing costs tied to both conditions.EN

A new study in Circulation suggests routine screening for Helicobacter pylori—a common stomach bacterium—could become standard care for coronary artery disease patients. The finding, if confirmed, could reshape clinical practice and create new demand for diagnostic testing in cardiology departments worldwide.EN

A new Lancet analysis points to three emerging disruptions—from technology to financing models—that could fundamentally alter how health systems operate worldwide. For health executives and policymakers, understanding these shifts is critical to anticipating investment opportunities and regulatory changes ahead.EN

A new trial compares a bare-bones digital tool against full therapist-guided online treatment for atopic dermatitis. If the simple app works as well as professional care, it could cut healthcare costs and expand access to millions suffering from the chronic skin condition while reducing pressure on stretched dermatology services.EN

A major Lancet review examines how European regulators can safely approve psychedelic drugs for mental health conditions, signaling a shift toward legitimizing these compounds in mainstream medicine. The framework matters to pharmaceutical companies, healthcare systems, and policymakers weighing clinical benefits against public health concerns.EN

Factor XI inhibitors, a promising new class of cardiovascular drugs, carry a serious bleeding risk for high-risk patients that researchers say warrants careful clinical scrutiny. The finding matters to pharmaceutical companies developing these agents, hospital networks implementing new protocols, and policymakers determining coverage and approval pathways.EN

Researchers have mapped how cancer cells reach the brain, a process that kills thousands annually and leaves survivors with severe cognitive damage. The findings could unlock new drug targets and prevention strategies, offering hope for patients facing one of oncology's most lethal complications.EN

Researchers have identified oxysterols—oxidized cholesterol compounds—as a common driver of inflammation in infections and non-communicable diseases like diabetes and heart disease. The finding could reshape how drugmakers approach treating conditions spanning infectious disease to metabolic disorders, potentially opening a single therapeutic target for multiple disease areas.EN

A new analysis in The Lancet Microbe identifies pregnant and postpartum women as a vulnerable population often missed during Group A streptococcal disease outbreaks. Health systems and public health agencies need better protocols to protect this high-risk group, which faces serious complications including sepsis and preterm delivery.EN

A new scoping review identifies the key obstacles and enablers for implementing trauma quality improvement programs in hospitals worldwide, with findings that differ sharply between wealthy and low-income countries. The research has immediate implications for health systems seeking to reduce trauma deaths and for organizations funding global health initiatives.EN

A major review of 71 studies found that while most research suggests chewing aids digestion and nutrition, the quality of evidence is too low to draw firm conclusions. The finding challenges long-held assumptions about oral health's downstream effects and could reshape how doctors advise patients on eating habits.EN

Adrenal cysts are becoming recognized as a significant but underdiagnosed condition, according to a major review in Nature Reviews Endocrinology. The findings could reshape how clinicians screen for and manage these growths, with implications for healthcare systems deciding whether to expand imaging protocols and specialist training.EN

A new study in Lancet Microbe reveals how a fourth SARS-CoV-2 vaccine dose generates immune responses at the body's mucous membranes—a finding with implications for public health policy and vaccine development strategy. The results could inform decisions about booster schedules and help manufacturers optimize next-generation vaccines.EN

A new study examines how combining inactivated virus vaccines with mRNA boosters protects against rapidly evolving COVID strains including BF.7, BQ.1.1, and XBB.1. The findings could inform public health vaccine strategies as the virus continues mutating and influence pharmaceutical companies' development of variant-specific boosters.EN

Researchers have identified autonomic nervous system dysfunction and postural orthostatic tachycardia syndrome as complications of long COVID, conditions that cause abnormal heart rate spikes when standing. The findings could help clinicians diagnose and treat a debilitating subset of long COVID patients and inform disability and insurance policy decisions.EN